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A B S T R A C T
Three aspartic proteases (SVAPs) have been isolated from venom of the saw-scaled viper, Echis ocellatus. In
confirmation of prior transcriptomic predictions, all three forms match to sequences of either of the two SVAP
transcripts (EOC00051 and EOC00123), have a molecular weight of 42 kDa and possess a single N-glycan.
The SVAPs act in a renin-like manner, specifically cleaving human and porcine angiotensinogen into an-
giotensin-1 and possess no general protease activity. Their activity is completely inhibited by the aspartyl pro-
tease inhibitor Pepstatin A.
© 2017.
In a previous study we presented evidence for the existence of
renin-like aspartic proteases in the venom gland transcriptome of the
West African (Nigeria) saw-scaled viper, Echis ocellatus (Wagstaff
and Harrison, 2006). This was the first report of this protein group
being expressed in snakes. Full-length sequences of two aspartic pro-
teases were determined, EOC00051 [AM180265] and EOC00123
[AM180266], and in both the presence of a signal peptide sequence
was identified. This, and the absence of lysosomal targeting se-
quences, strongly indicated that these proteases would be secreted
components of venom. Analysis of the two sequences also revealed
>50% overall sequence identity with human (P00797) and mouse
(P06281) renin-1, including conserved cysteine patterns and catalytic
residues. Our evidence thus suggested that aspartic proteases with
renin-like activity may be E. ocellatus venom components and there-
fore function as a new class of venom toxins. Here we outline the re-
sults of further studies carried out to isolate these proteases from the
venom and confirm their renin-like activity.
1. Confirmation of aspartic proteases in venom of E. ocellatus
To detect aspartic proteases in venom, we first generated a poly-
clonal antibody specific to E. ocellatus venom aspartic proteases
(SVAP) by immunizing a rabbit with a multi-antigenic
RYDSSESSTYKPKGT peptide immunogen: this peptide corresponds
to residues 122–136 of both translated transcripts, EOC00051 and
EOC00123. This antibody reacted with a band at approximately
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42 kDa in immunoblots of E. ocellatus (i) whole venom and (ii) gel
filtration chromatography (GFC)-separated venom proteins (data not
shown). This band was evident on Coomassie blue-stained venom
SDS-PAGE gels (at a level estimated to be equivalent to around 2%
of total venom protein as predicted by our transcriptional data) and
was excised and subjected to in-gel trypsin digestion for peptide mass
analysis. Nine of the resultant peptides matched sequences of the orig-
inal SVAP transcripts (Table 1, column WV). In addition to these
matching peptide masses, we obtained the sequence of the tryptic pep-
tide GFFSQDIVR (res 149–157) by ES-MS-MS. This venom pro-
teomic data clearly confirmed that the protein[s] contained in this band
matched to the transcripts EOC00123 and EOC00051 in the E. ocella-
tus transcriptome.
2. Isolation of three isoforms of venom aspartic proteases
Following identification of the 42 kDa band as the putative SVAP,
we set out to isolate sufficient amounts of the purified protein for
function analysis. Fifty mg of E. ocellatus (Nigeria) venom in 5 mL
PBS (50 mM sodium phosphate, 150 mM NaCl, pH 7.2) was sub-
jected to gel filtration chromatography (GFC) on a 90 cm × 2.6 cm
Superdex 200 column. Elution was carried out at 2.0 mL/min. The pu-
tative SVAP (42 kDa band on SDS-PAGE) was partially purified by
this chromatographic procedure, eluting just after the 65 kDa venom
metalloproteases. Further purification was carried out using anion ex-
change chromatography on a 1 mL Mono Q column (GE Health-
care), eluting with a 0–0.3 M gradient of NaCl in 50 mM Tris-Cl,
pH 7.8. Multiple peaks were routinely detected for the SVAPs us-
ing this separation method, providing evidence for at least three main
isoforms, which we designated SVAP B1, SVAP A1
http://dx.doi.org/10.1016/j.toxicon.2017.07.008
0041-0101/© 2017.
UN
CO
RR
EC
TE
D
PR
OO
F
2 Toxicon xxx (2017) xxx-xxx
Table 1
Peptide mass matches from the MALDI-TOF spectrum of peptides obtained through
in-gel digestion of 42 kDa bands from SDS-PAGE gels of whole venom [WV], or fol-
lowing digestion of isolated SVAP isoforms AI, B1 and B2.
Mass (Da) Peptide WV A1 B1 B2
3309.6 HSESNTGGEIILGGSDPSHYTGDFHYVSTSR Y
3190.6 VVFDTGSSNLWVPSHQCSPLYSACVSHNR Y Y Y
2274.3 ITLTYGQGYIEGFLSQDIVR Y Y Y
2032.1 DTQYYGEISIGTPAQIFK Y
1819.1 QAIGGVIPVFDNIMSEK Y
1664.0 Y Y
1562.9 VLSENVFSVYYSR Y Y Y Y
1315.8 GPLWLLGATFIK Y Y Y
1068.5 Y Y
Sequences were obtained from the theoretical digest tool (http://ca.expasy.org/tools/
peptide-mass.html). Double-underlined sequences (═) are unique to EOC00051,
single-underlined sequences (─) are unique to EOC00123 and sequences possessing no
underlining are common to both isoforms.
and SVAP B2 (in order of elution from Mono Q) based on their
sequence matches to the transcripts (EOC00051 = form A;
EOC00123 = form B, see Table 1). A third chromatography step was
carried out in order to acquire highly purified samples of SVAP A1,
SVAP B1 and SVAP B2 isoforms. Mono Q fractions containing both
SVAP A1 and SVAP B1 were loaded onto a 1 mL Phenyl Superose
hydrophobic interaction chromatography (HIC) column (GE Health-
care) equilibrated in 50 mM TrisCl, 3 M NaCl, pH 7.8 and eluted with
a gradient of decreasing NaCl concentration. The two isoforms A1
and B1 were fully separated from each other using HIC. SVAP B2
was also further purified on HIC during which it chromatographed as
a single peak. SDS-PAGE analysis of three purified isoforms (Fig.
1A) reveals that SVAP A1 has a slightly lower molecular mass than
that of SVAP B1 and SVAP B2. Multiple bands can be seen for each
isoform suggesting further structural variation within each isoform.
This variation may be due to the presence of glycoforms: all three iso-
forms ran with higher mobility on SDS-PAGE following overnight
treatment with PNGase F to remove N-glycans; the apparent mwt de-
creased by Ca. 4 kDa, suggesting a single N-glycan (data not shown).
Both transcript sequences have a single potential N-glycosylation site
at residue 64. Using trypsin digestion and mass spectrometry [MS]
analysis to isolate and identify peptides unique to either of the two
transcripts, we were able to confirm that SVAP A1 is derived from
EOC00051, whereas SVAP B1 and SVAP B2 are derived from tran-
script EOC00123 (Table 1).
Fig. 1. A SDS-PAGE analysis of isolated SVAP isoforms. Each of the three main SVAP isoforms (lanes B1, A1, B2) were checked for purity on a 12% polyacrylamide gel. The
samples have not been adjusted to equalise concentration prior to loading, so the staining intensity gives an approximate indication of the relative quantities of each isoform in the
venom. The gels were silver stained according to the method of Heukeshoven and Dernick (1985). Lane S, molecular weight standards, from top to bottom are 67, 45, 37, 29, 24, 20
and 14 kDa. Each band contains 15 ng of protein. B RP-HPLC and MS analysis of renin assay substrates and products. Various combinations of SVAP B1 (10 μg/mL), human
angiotensinogen (100 μg/mL) were incubated in PBS at 37 °C for 4 h. The reaction was stopped with 0.5% (v/v) TFA and peptides were separated with a 20 min, 0–65% gradient of
acetonitrile in 0.1% TFA. Isolated substrate/products were analysed by MS and the M+H+ values found are shown next to the relevant peak. Lower trace is angiotensinogen control;
upper trace is SVAP + angiotensinogen. C. Analysis of the general proteolytic activity of SVAP B1. Various combinations of SVAP B1 (10 μg/mL), alpha casein, beta casein (100
μg/mL) and GFC-isolated metalloprotease (20 μg/mL) were incubated in PBS at 37 °C for 4 h. Ten uL samples of each incubation mixture were loaded onto a 15% polyacrylamide
gel and subsequently stained with Coomassie Blue R250. Lane 1 alpha casein alone; lane 2, beta casein alone; lane 3, SVAP B1 alone; lane 4, alpha casein incubated with SVAP
B1; lane 5, beta casein incubated with SVAP B1; lane 6, alpha and beta casein (mixed) incubated with metalloprotease; lane S, molecular weight standards, from top to bottom are
67, 45, 37, 29, 24, 20 and 14 kDa.
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3. Confirmation of the renin-like function of venom aspartic
proteases
Since SVAP B1 was routinely found to be the most abundant of
the three isoforms in E. ocellatus venom, this protein was used to
develop the assay for renin-like activity. The assay incubation mix-
ture contained the tetradecapeptide substrate, human angiotensinogen
(DRVYIHPFHLVIHN; at a concentration of 100 μg/mL in PBS) with
SVAP B1 at 10 μg/mL and was incubated at 37 °C for 1–20 h. MS
was used to analyse the decapeptide (angiotensin-1, M+H+ 1296.0)
and tetrapeptide (VIHN, M+H+ 482.3) products arising from renin
like cleavage between residues 10 and 11. Although direct analysis for
angiotensin-1 on MALDI-TOF provided a rapid measure of renin-like
activity, a C18 reverse-phase HPLC separation of substrate and prod-
ucts along with subsequent MALDI-MS or ESI-MS analysis of the
peaks allowed for a semi-quantitative measure of activity and a more
complete analysis of the specificity of SVAP B1 towards the substrate
(example, Fig. 1B). The results of all these analyses confirmed the
renin-like specificity of SVAP B1. Thus, we identified (by both mass
and sequence) the presence of the tetrapeptide product VIHN which
hadn't been detectable using MALDI-MS. The presence of this peptide
product provided evidence for a specific cleavage event rather than
the possibility of a carboxypeptidase-like activity of the SVAP being
responsible for the generation of angiotensin-1 from angiotensinogen.
Under the conditions used here, conversion was typically 70–80%
complete within 3 h. This activity was almost completely inhibited
by the aspartyl protease inhibitor, Pepstatin A, at a concentration of
10 μM, but was not inhibited by the serine or metalloproteinase in-
hibitors, PMSF or EDTA. All three isoforms were shown to be active
towards human angiotensinogen and to be inhibited by 10 μM Pep-
statin A. These analyses were successfully repeated using porcine an-
giotensinogen (DRVYIHPFHLLVYS).
Using a lower purity SVAP fraction from the anion exchange sep-
aration, and with prolonged assay times with human angiotensinogen
we were able to detect small quantities of products with M+H+ values
of 551, 552, 763 and 1226. These are likely to be the angiotensino-
gen fragments RVYI, DRVY, IHPFL and IHPFLVIHN respectively
and are probably present due to the action of minor quantities of other
venom proteases, emphasising the need for the HIC separation step for
full purification of the SVAPs.
Purified SVAP B1 was tested for general protease activity by incu-
bating it at 10 μg/mL with 100 μg/mL alpha or beta casein. GFC-iso-
lated metalloprotease from the same venom batch was used as a pos-
itive control. Using the same conditions required to convert 80% + of
angiotensinogen to angiotensin-1, SVAP B1 appeared to have no pro-
teolytic activity towards the two caseins (Fig. 1C). In contrast, the
metalloprotease brought about a complete loss of the alpha casein
band and a partial digestion of beta casein.
The data presented here confirms the presence in E. ocellatus
venom of the aspartic proteases predicted from our transcriptional
studies (Wagstaff and Harrison, 2006) and that these possess the pos-
tulated renin-like activity. In this previous paper we discussed the pos-
sibility that entry of venom aspartic proteases into the vasculature
might be expected to induce local hypertension, which may compound
SVMP-induced tissue damage, but also systemic hypertension. How-
ever, we can find no evidence in the literature for systemic hyper-
tension following E. ocellatus envenomation, although such effects
may be masked by the complex and rapid pathology associated with
viper venom-induced haemorrhage. Indeed, there are very few stud-
ies in which hypertension has been demonstrated in the pathology of
envenoming by any snake species. In the few cases reporting hyper-
tension symptomology following envenoming by Vipera berus berus
(Malina et al., 2008); Proatheris superciliari (Valenta et al., 2008);
Bitis nasicornis (Malina and Krecsak, 2008) and Naja haje (Omran
and Abdel-Nabi, 1997), hypertension was not attributed to a specific
venom component. Where a component of the venom has been in-
dicated as being responsible for hypertension, it was thought to act
indirectly e.g. through metalloprotease-induced activation of inactive
renin in B. arietans (see Morris and Taylor, 1987). Thus, this study is
the first in which a venom component has been isolated that may be
directly responsible for hypertensive effects of envenomation.
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